Superstring Capital Management

Superstring Capital Management

Superstring Capital Management is a New York-based investment firm dedicated exclusively to global life sciences. The firm invests on behalf of a long-term institutional capital base that it describes as including university endowments, sovereign wealth funds, medical foundations, and family offices. The team is built from life sciences investment specialists with significant biopharma industry experience, trained at what the firm calls preeminent academic and business institutions. The firm invests across both public and private markets in pharmaceutical, biotech, medtech, and healthcare services companies. Its mandate spans early-stage private placements and public-company positions, giving it a cross-over capability that is structural rather than opportunistic. Superstring emphasizes fundamental, science-driven research as the core of its investment process. The firm states it leverages in-depth industry, commercial, and regulatory knowledge to collaborate with portfolio companies. No named portfolio holdings or specific deal sizes were publicly disclosed. Superstring is headquartered in New York. Additional office locations, team size, and total assets under management were not publicly disclosed by the firm. No specific adjacent vehicles, philanthropic foundations, or co-investor club memberships could be identified from available sources. No dated operational event from the last 24 months could be confirmed. The firm's structural distinction is its pure-play healthcare mandate backed by permanent institutional capital — endowments, sovereign funds, and medical foundations — rather than by a single family or a fund-of-funds redemption schedule. This capital architecture is designed for long-duration science exposure across both private and public markets. The firm's stated posture is to act as a collaborative partner to portfolio companies, though the specific governance or operational engagement model was not detailed in available materials.